The Single cell omics Market size was valued at USD 4.99 Billion in 2024 and the total Single cell omics revenue is expected to grow at a CAGR of 24.9% from 2025 to 2032, reaching nearly USD 29.60 Billion.
Single-cell Omics Market Mergers & Acquisitions / Recent Developments
The single-cell omics market has experienced notable mergers and acquisitions, reflecting the industry's dynamic nature. In March 2022, Singleron Biotechnologies acquired Proteona Pte. Ltd., aiming to expand its global footprint and access Proteona's advanced single-cell multi-omic analysis technologies. This strategic move underscores the importance of technological integration in maintaining competitive advantage.
Recent developments also highlight the market's innovation trajectory. For instance, in October 2024, 10x Genomics unveiled two new Chromium products, GEM-X Flex and GEM-X Universal Multiplex, designed to enhance accessibility and affordability in single-cell analysis. Similarly, BD launched the BD OMICS-One XT WTA Assay, a high-throughput, robotics-compatible reagent kit, streamlining single-cell workflows and accelerating discovery in oncology and immunology.
Ask for Sample to Know US Tariff Impacts on Market @https://www.maximizemarketresearch.com/request-sample/187051/
Single cell omics Market Report Scope and Research Methodology :
The primary objective of the Global Single cell omics Market report is to deliver a comprehensive analysis of the market in accessible language for stakeholders. The research has involved segmenting the Single cell omics market into major categories, which were further subdivided into various sub-segments. The report offers a detailed examination of drivers, opportunities, restraints, and challenges within the Single cell omics industry, segmented both regionally and by segment.
The report on the Single cell omics Market furnishes an exhaustive analysis, incorporating historical data, insightful perspectives, facts, and statistically validated market statistics. These statistics are based on a well-founded set of assumptions and methodologies. The collection of data for the Single cell omics market report relied on both primary and secondary research methods. This amalgamated data was meticulously analyzed to produce precise and reliable findings.
Incorporating secondary research, the report delves into annual and financial reports of leading players, while primary research involves interviews with key opinion leaders and experts within the Single cell omics industry, including frontline personnel, entrepreneurs, and marketing professionals. The estimation of the Single cell omics market size was achieved through a bottom-up approach. The report employs SWOT analysis to outline the strengths and weaknesses of the Single cell omics Market, and leverages PESTLE and PORTER analyses to outline the impacts of macroeconomic and microeconomic factors on the global Single cell omics Market.
For Customization of the report, please refer to this link:https://www.maximizemarketresearch.com/inquiry-before-buying/187051/
Single cell omics Market Regional Insights :
Geographically, the report is segmented into several key countries, with Single cell omics market size, growth rate, import and export of Single cell omics market in these countries, which cover North America, U.S., Canada, Mexico, Europe, UK, Germany, France, Spain, Italy, Rest of Europe, Asia Pacific, China, India, Japan, Australia, South Korea, ASEAN Countries, Rest of APAC, South America, Brazil, and the Middle East and Africa.
Single cell omics Market Segmentation :
by Application
Oncology
Neurology
Immunology
Cell Biology
Oncology: One of the most notable growth areas has been oncology applications. Single-cell multi-omics (scMulti-omics) has been a tremendous success in identifying key regulators of antitumor immunology and characterizing immune subsets, bringing revolutionary insights into immuno-oncology. New avenues for oncology applications have also been made possible by expanded research on cancer therapy. The market for single-cell omics has enormous potential in cell biology since single-cell RNA sequencing can provide a multitude of details regarding the signaling pathways and patterns of gene expression in individual cells.
by Technology
Cell isolation technologies
Sample preparation technologies
Analysis of next-generation sequencing
Flow cytometry and selective single cell isolation are the two basic components of cell isolation technology. Flow cytometry-based cell isolation methods like magnetic activated cell sorting (MACS) and fluorescence activated cell sorting (FACS) separate cells based on their magnetic or fluorescence labeling. Because more people are being diagnosed with diseases like HIV and cancer, single cell omics has grown by over 8% annually.
by Type
Genomics
Transcriptomics
Metabolomics
Proteomics
Clinical illness detection is one use for single cell genomics, and significant developments in healthcare, particularly in liquid biopsies, have opened up new opportunities for the single cell omics market. After the pandemic, the genomics market has grown by up to 25% overall, indicating that the market is expanding on its own. Single-cell genomics thus becomes a significant category.
by End - User
Pharma companies
Research institutions
Clinical Laboratories
The market for single cell omics can be categorized according to its end users, which include academic research institutions, clinical laboratories, and pharmaceutical and biotechnology businesses. Because the pharmaceutical industry has a well-established market and has rigorous standards, pharmaceutical businesses enjoy a good market share. Due to significant investments in the industry, the number of clinical laboratories is also growing.
Interested to take a sneak peek? Request a sample copy of the report to see what's inside:https://www.maximizemarketresearch.com/request-sample/187051/
Single cell omics Market Key Players :
1. 10x Genomics (US)
2. Illumina (US)
3. Bio-Techne (US)
4. Onramp Bioinformatics (US)
5. ACGT: (South Africa)
6. Vizgen Biosciences (US)
7. 10x Genomics (US)
8. Fluidigm (US)
9. Mission Bio (US)
10.Becton, Dickinson and Company (US)
11.NuGEN Technologies (US)
12.WaferGen Biosystems (US)
13.Agilent Technologies (US)
14.GenapSys (US)
15.Bio-Rad Laboratories (US)
16.Genosha: (Chile)
17.SiMMo3D: (Brazil)
18.Takara Bio (Japan)
19.Oxford Nanopore Technologies (UK)
20.Dolomite Bio (UK)
21.QIAGEN (Netherlands)
22.CytoSMART Technologies (Netherlands)
23.Takara Bio (Japan)
24.OriGen Biomedical: (UAE)
25.Saudi Biosciences: (Saudi Arabia)
Key Questions answered in the Single cell omics Market Report are:
Key Offerings:
Latest cutting-edge research from Maximize Market Research is now trending:
Global Antibacterial Drugs Market https://www.maximizemarketresearch.com/market-report/global-antibacterial-drugs-market/23877/
global NonSmall Cell Lung Cancer Therapeutics Market https://www.maximizemarketresearch.com/market-report/global-non-small-cell-lung-cancer-therapeutics-market/39017/
About Maximize Market Research:
Maximize Market Research is a multifaceted market research and consulting company with professionals from several industries. Some of the industries we cover include medical devices, pharmaceutical manufacturers, science and engineering, electronic components, industrial equipment, technology and communication, cars and automobiles, chemical products and substances, general merchandise, beverages, personal care, and automated systems. To mention a few, we provide market-verified industry estimations, technical trend analysis, crucial market research, strategic advice, competition analysis, production and demand analysis, and client impact studies.
Contact Maximize Market Research:
3rd Floor, Navale IT Park, Phase 2
Pune Banglore Highway, Narhe,
Pune, Maharashtra 411041, India
sales@maximizemarketresearch.com
+91 96071 95908, +91 9607365656
| Price: | 411041 |
| Categories: | Services / Health & Beauty Services |
| Phone: | 9607365656 |
| Address: | 3rd Floor, Navale IT park Phase 2, |
| Email: | rajnandinimaximize@gmail.com |
